Release Date: 07/12/11 16:06 Summary: Appendix 3Y - Change of Director's Interest - Parish Price Sensitive: No Download Document 70.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%